Harrow Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Harrow Health, Inc. on May 22, 2019. The report serves as a current disclosure pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The filing primarily addresses Regulation FD Disclosure regarding a corporate presentation used by management at investor conferences.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the existence of a presentation rather than a financial statement.
Material Changes
No material changes to financial performance or operations are reported in this specific filing. The document does not contain comparative period data.
Guidance, Outlook, and Risks
Item 7.01 discloses the attachment of a corporate presentation (Exhibit 99.1) dated May 2019. The filing explicitly states that the information contained in the presentation is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated. Consequently, no specific guidance, outlook, or risk factors are detailed within the text of this 8-K.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Corporate Presentation dated May 2019) for any forward-looking statements or strategic updates, as the 8-K itself only references the document.
- Note that the presentation materials are not legally "filed" with the SEC and do not carry the same liability protections as formal financial reports.
- Confirm the company's current financial status through its most recent 10-K or 10-Q filings, as this 8-K contains no financial data.